Skip to content

Topics: Medical research

  • Study finds losing a night of sleep may increase blood levels of Alzheimer’s biomarker

    A preliminary study by researchers at Uppsala University has found that when young, healthy men were deprived of just one night of sleep, they had higher levels of tau – a biomarker for Alzheimer’s disease – in their blood than when they had a full, uninterrupted night of rest. The study is published in the medical journal Neurology.

  • Smart algorithm finds possible future treatment for childhood cancer

    Using a computer algorithm, scientists at Uppsala University have identified a promising new treatment for neuroblastoma. This form of cancer in children, which occurs in specialised nerve cells in the sympathetic nervous system, may be life-threatening.

  • ​Variability in the molecules of life

    How variable are gene transcripts and proteins, the molecules of life, across the tissues and organs of the human body? Furthermore, how variable are they within the same tissue type from different people? These questions are the focus of a new study led by researchers from Uppsala University, which is published in NAR Genomics and Bioinformatics.

  • New mechanism for dysfunctional insulin release identified

    In a new study, researchers at Uppsala University have identified a previously unknown mechanism that regulates release of insulin, a hormone that lowers blood glucose levels, from the β-cells (beta cells) of the pancreas. This mechanism is disrupted in type 2 diabetes. The scientists hope this finding will be used to develop new treatments against the disease.

  • Deaths halved among infarct patients attending Heart School

    ​Patients who attend ‘Heart School’, as almost every patient is invited to do after a first heart attack, live longer than non-participating patients. This is shown in a new study, by researchers at Uppsala University, published in the European Journal of Preventive Cardiology.

  • New WHO autoantibody reference reagent will benefit SLE patients

    Reference reagents are important in diagnostics and care of patients with systemic lupus erythematosus (SLE). An international team of researchers now presents a WHO autoantibody reference reagent that will help to align autoantibody analyses and thus to optimise diagnosis and treatment to patients irrespective of where they live. The findings are published in Annals of the Rheumatic Diseases.

  • Novel method identifies the right individual exosomes

    There is a growing demand for diagnostic markers for early disease detection and prognosis. Exosomes are potential biomarkers for cancer progression and neurodegenerative disease but it can be difficult to identify what tissue a specific exosome comes from. Researchers have solved this problem by developing a method that maps surface protein complements on large numbers of individual exosomes.

  • Multiple genes affect risk of asthma, hay fever and eczema

    In a new study from SciLifeLab at Uppsala University, researchers have found a total of 141 regions (genes) in our genetic material that largely explain the genetic risk underlying asthma, hay fever and eczema. As many as 41 of the genes identified have not previously been linked to an elevated risk for these diseases. The results are published in the scientific journal Human Molecular Genetics.

  • ​How bacteria translate proteins from structurally blocked mRNAs - using standby

    Bacterial ribosomes need a single-stranded ribosome binding site (RBS) to initiate protein synthesis, whereas stable RNA structure blocks initiation. Paradoxically, structured mRNAs can nevertheless be efficiently translated. Researchers at Uppsala University have now elucidated the anatomy of a "standby" site and its requirements, to overcome RNA structure problems for translation.

  • ​New biomarker test improves diagnosis of ovarian cancer

    The majority of women who undergo surgery for suspected ovarian cancer do not have cancer. A novel blood test developed by researchers at Uppsala University and University of Gothenburg, now offers the possibility of more precise diagnostics. This could lead to a reduction in unnecessary surgery and to earlier detection and treatment for affected women. (Communications Biology).

  • New genes out of nothing

    One key question in evolutionary biology is how novel genes arise and develop. Swedish researchers now show how new genes and functions that are advantageous to bacteria can be selected from random DNA sequences. The results are presented in the scientific journal mBio.

  • Inhibition of ribosome biogenesis as a novel approach for multi-stage cancer treatment

    Nearly ninety per cent of all cancer patient deaths are due to metastasis. A study from Uppsala University shows that a process that allows the cells to metastasise is aided by the synthesis of new ribosomes, the cell components in which proteins are produced. The results open the possibility for new treatment strategies for advanced cancers. The study is published in Nature Communications.

  • Association between high blood PCB levels and premature death

    High levels of polychlorinated biphenyls (PCBs) in the blood are associated with premature death. This is shown by a cross-disciplinary study, based on 1,000 randomly selected 70-year-olds in Uppsala, that is published in the JAMA Network Open journal today.

  • Simple method rescues stressed liver cells

    Isolated human hepatocytes are essential tools in preclinical and clinical liver research, but cell quality is highly variable. Now, researchers from Uppsala University have devised a simple protocol that improves hepatocyte quality and enables cells from a wider quality spectrum to be used in standard and advanced cell culture. The findings are published in Archives of Toxicology.

  • Surgery unnecessary for many prostate cancer patients

    Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian men with prostate cancer for 29 years. The results are now published in The New England Journal of Medicine.

  • Deciding not to resuscitate: nurses’ and physicians’ perspectives

    When deciding not to resuscitate patients in cardiac arrest, ethical issues arise. Nurses and physicians conflicting perspectives often cause frustration. In a new doctoral thesis from Uppsala University, Mona Pettersson examines clinical and ethical perspectives on “DNR orders” in cancer care.

  • Genetic risk: Should researchers let people know?

    Should researchers inform research participants, if they discover genetic disease risks in the participants? The value of complex genetic risk information for individuals is uncertain. In a PhD thesis from Uppsala University, Jennifer Viberg Johansson suggests that this uncertainty needs to be acknowledged by both geneticists and ethicists.

  • Bravery cells found in the hippocampus

    Why do some people comfortably walk between skyscrapers on a high-wire or raft the Niagara Falls in a wooden barrel whereas others freeze on the mere thought of climbing off escalators in a shopping mall? In a new study, scientists have found that a certain type of cells in the hippocampus play a key role.

  • Extent of immune response associated with degree of inflammation and joint damage in rheumatoid arthritis

    To diagnose rheumatoid arthritis, antibodies to the amino acid citrulline are commonly measured. A new study from Uppsala University shows that a broad mix of different antibodies in the joints is the dominant factor that can be associated with severe inflammation and joint damage. These findings, published in Annals of the Rheumatic Diseases, may eventually lead to improved diagnostics.

Show more